These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 28884236)

  • 41. Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virus.
    Oem JK; Chang BS; Joo HD; Yang MY; Kim GJ; Park JY; Ko YJ; Kim YJ; Park JH; Joo YS
    J Virol Methods; 2007 Jun; 142(1-2):174-81. PubMed ID: 17336400
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Generation of mAbs to foot-and-mouth disease virus serotype A and application in a competitive ELISA for serodiagnosis.
    Yang M; Xu W; Bittner H; Horsington J; Vosloo W; Goolia M; Lusansky D; Nfon C
    Virol J; 2016 Nov; 13(1):195. PubMed ID: 27894355
    [TBL] [Abstract][Full Text] [Related]  

  • 43. High-yield production of the VP1 structural protein epitope from serotype O foot-and-mouth disease virus in Escherichia coli.
    Jung JG; Lee YJ; Velmurugan N; Ko YJ; Lee HS; Jeong KJ
    J Ind Microbiol Biotechnol; 2013 Jul; 40(7):705-13. PubMed ID: 23619971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
    Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
    Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Structures of Foot-and-mouth Disease Virus with neutralizing antibodies derived from recovered natural host reveal a mechanism for cross-serotype neutralization.
    He Y; Li K; Cao Y; Sun Z; Li P; Bao H; Wang S; Zhu G; Bai X; Sun P; Liu X; Yang C; Liu Z; Lu Z; Rao Z; Lou Z
    PLoS Pathog; 2021 Apr; 17(4):e1009507. PubMed ID: 33909694
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Eight novel single chain antibody fragments recognising VP2 of foot-and-mouth disease virus serotypes A, O, and SAT 2.
    Salem R; El-Kholy AA; Ibrahim M
    Virology; 2019 Jul; 533():145-154. PubMed ID: 31170612
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of novel epitopes in serotype O foot-and-mouth disease virus by in vitro immune selection.
    Mahapatra M; Upadhyaya S; Parida S
    J Gen Virol; 2019 May; 100(5):804-811. PubMed ID: 30990405
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunogenicity and protective efficacy of a novel foot-and-mouth disease virus empty-capsid-like particle with improved acid stability.
    Xie Y; Li H; Qi X; Ma Y; Yang B; Zhang S; Chang H; Yin X; Li Z
    Vaccine; 2019 Mar; 37(14):2016-2025. PubMed ID: 30808570
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recombinant adenovirus expressing type Asia1 foot-and-mouth disease virus capsid proteins induces protective immunity against homologous virus challenge in mice.
    Zhou G; Wang H; Wang F; Yu L
    Res Vet Sci; 2013 Jun; 94(3):796-802. PubMed ID: 23267820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Identification of two novel BTV16-specific B cell epitopes using monoclonal antibodies against the VP2 protein.
    Wang WS; Sun EC; Xu QY; Yang T; Qin YL; Zhao J; Feng YF; Li JP; Wei P; Zhang CY; Wu DL
    Appl Microbiol Biotechnol; 2013 Jul; 97(13):5933-42. PubMed ID: 23467824
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of a blocking ELISA based on a monoclonal antibody against a predominant epitope in non-structural protein 3B2 of foot-and-mouth disease virus for differentiating infected from vaccinated animals.
    Fu Y; Lu Z; Li P; Cao Y; Sun P; Tian M; Wang N; Bao H; Bai X; Li D; Chen Y; Liu Z
    PLoS One; 2014; 9(11):e111737. PubMed ID: 25369323
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenovirus-vectored type Asia1 foot-and-mouth disease virus (FMDV) capsid proteins as a vehicle to display a conserved, neutralising epitope of type O FMDV.
    Chai Z; Wang H; Zhou G; Yang D; Wang J; Yu L
    J Virol Methods; 2013 Mar; 188(1-2):175-82. PubMed ID: 22981982
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Protection of a novel epitope-RNA VLP double-effective VLP vaccine for foot-and-mouth disease.
    Dong YM; Cai JC; Chen HT; Chen L
    Antiviral Res; 2016 Oct; 134():108-116. PubMed ID: 27565990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Generation of monoclonal antibodies against foot-and-mouth disease virus SAT 2 and the development of a lateral flow strip test for virus detection.
    Yang M; Mudabuka B; Quizon K; Nfon C
    Transbound Emerg Dis; 2019 May; 66(3):1158-1166. PubMed ID: 30462886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Immunogenicity of adenovirus-derived porcine parvovirus-like particles displaying B and T cell epitopes of foot-and-mouth disease.
    Pan Q; Wang H; Ouyang W; Wang X; Bi Z; Xia X; Wang Y; He K
    Vaccine; 2016 Jan; 34(4):578-585. PubMed ID: 26685093
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.
    Zhang Z; Pan L; Ding Y; Zhou P; Lv J; Chen H; Fang Y; Liu X; Chang H; Zhang J; Shao J; Lin T; Zhao F; Zhang Y; Wang Y
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1389-98. PubMed ID: 25381487
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A computational study of the interaction of the foot and mouth disease virus VP1 with monoclonal antibodies.
    Marrero R; Limardo RR; Carrillo E; König GA; Turjanski AG
    J Immunol Methods; 2015 Oct; 425():51-57. PubMed ID: 26093030
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Monoclonal antibodies, against O1 serotype foot-and-mouth disease virus, from a natural bovine host, recognize similar antigenic features to those defined by the mouse.
    Barnett PV; Samuel AR; Pullen L; Ansell D; Butcher RN; Parkhouse RM
    J Gen Virol; 1998 Jul; 79 ( Pt 7)():1687-97. PubMed ID: 9680132
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Single immunization with a recombinant multiple-epitope protein induced protection against FMDV type Asia 1 in cattle.
    Fang M; Wang H; Tang T; Zhao P; Du J; Guo S; Wei H; Xu H; Wan M; Wei X; Yu Y; Wang L
    Int Immunopharmacol; 2015 Oct; 28(2):960-6. PubMed ID: 26365702
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity of a recombinant fusion protein of tandem repeat epitopes of foot-and-mouth disease virus type Asia 1 for guinea pigs.
    Zhang Q; Yang YQ; Zhang ZY; Li L; Yan WY; Jiang WJ; Xin AG; Lei CX; Zheng ZX
    Acta Virol; 2002; 46(1):1-9. PubMed ID: 12199204
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.